Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S.

BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z.

2.

Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top-Down Proteomics: A Pilot Study.

Molinari N, Roche S, Peoc'h K, Tiers L, Séveno M, Hirtz C, Lehmann S.

Front Mol Neurosci. 2018 Dec 18;11:477. doi: 10.3389/fnmol.2018.00477. eCollection 2018.

3.

Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry.

Incamps A, Saez-Boiteau C, Tiede SL, Rebillard P, Schulte J, Vialaret J, Beinrucker A, Lehmann S, Hirtz C.

Bioanalysis. 2018 Sep 1;10(17):1383-1399. doi: 10.4155/bio-2018-0149. Epub 2018 Sep 12.

PMID:
30207162
4.

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.

Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, Alcolea D, Pegueroles J, Muñoz L, Belbin O, de Leon MJ, Maceski AM, Hirtz C, Clarimón J, Videla S, Delaby C, Lehmann S, Blesa R, Lleó A.

Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29.

PMID:
30172624
5.

Alzheimer's Disease: Advances in Drug Development.

Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A.

J Alzheimers Dis. 2018;65(1):3-13. doi: 10.3233/JAD-180145.

PMID:
30040716
6.

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

Vialaret J, Schmit PO, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C.

Data Brief. 2018 Mar 31;18:1013-1021. doi: 10.1016/j.dib.2018.03.114. eCollection 2018 Jun.

7.

Data from a targeted proteomics approach to discover biomarkers in saliva for the clinical diagnosis of periodontitis.

Orti V, Mertens B, Vialaret J, Gibert P, Relaño-Ginés A, Lehmann S, Deville de Périère D, Hirtz C.

Data Brief. 2018 Mar 12;18:294-299. doi: 10.1016/j.dib.2018.03.036. eCollection 2018 Jun.

8.

Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.

Hirtz C, Bros P, Brede C, Lescuyer P, Maceski AM, Vialaret J, Delatour V, Lehmann S; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Crit Rev Clin Lab Sci. 2018 Aug;55(5):346-358. doi: 10.1080/10408363.2018.1470159. Epub 2018 May 23.

PMID:
29792094
9.

What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum?

Vialaret J, Broutin S, Pugnier C, Santelé S, Jaffuel A, Barnes A, Tiers L, Pelletier L, Lehmann S, Paci A, Hirtz C.

Bioanalysis. 2018 May 1;10(10):723-735. doi: 10.4155/bio-2018-0027. Epub 2018 May 17.

PMID:
29771137
10.

Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings?

Vialaret J, Picas A, Delaby C, Bros P, Lehmann S, Hirtz C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 1;1086:110-117. doi: 10.1016/j.jchromb.2018.04.003. Epub 2018 Apr 10.

PMID:
29660664
11.

Association between serum hepcidin level and restless legs syndrome.

Dauvilliers Y, Chenini S, Vialaret J, Delaby C, Guiraud L, Gabelle A, Lopez R, Hirtz C, Jaussent I, Lehmann S.

Mov Disord. 2018 Apr;33(4):618-627. doi: 10.1002/mds.27287. Epub 2018 Feb 8.

PMID:
29418021
12.

Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samples.

Mertens B, Orti V, Vialaret J, Gibert P, Relaño-Ginés A, Lehmann S, de Périère DD, Hirtz C.

Bioanalysis. 2018 Jan;10(1):35-45. doi: 10.4155/bio-2017-0218. Epub 2017 Dec 15.

PMID:
29243487
13.

Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.

Lasocki S, Puy H, Mercier G, Lehmann S; Hepcidane study group.

Anaesth Crit Care Pain Med. 2017 Dec;36(6):391-396. doi: 10.1016/j.accpm.2017.04.009. Epub 2017 Sep 14.

PMID:
28919067
14.

Towards a routine application of Top-Down approaches for label-free discovery workflows.

Schmit PO, Vialaret J, Wessels HJCT, van Gool AJ, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C.

J Proteomics. 2018 Mar 20;175:12-26. doi: 10.1016/j.jprot.2017.08.003. Epub 2017 Aug 30.

PMID:
28855124
15.

Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods.

Lehmann S, Picas A, Tiers L, Vialaret J, Hirtz C.

Crit Rev Clin Lab Sci. 2017 May;54(3):173-184. doi: 10.1080/10408363.2017.1297358. Epub 2017 Apr 10. Review.

PMID:
28393579
16.

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

Gabelle A, Jaussent I, Hirtz C, Vialaret J, Navucet S, Grasselli C, Robert P, Lehmann S, Dauvilliers Y.

Neurobiol Aging. 2017 May;53:59-66. doi: 10.1016/j.neurobiolaging.2017.01.011. Epub 2017 Jan 18.

PMID:
28235679
17.

Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC system.

Maleska A, Hirtz C, Casteleyn E, Villard O, Ducos J, Avignon A, Sultan A, Lehmann S.

Bioanalysis. 2017 Mar;9(5):427-434. doi: 10.4155/bio-2016-0278. Epub 2017 Feb 13.

PMID:
28220711
18.

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.

Viziteu E, Klein B, Basbous J, Lin YL, Hirtz C, Gourzones C, Tiers L, Bruyer A, Vincent L, Grandmougin C, Seckinger A, Goldschmidt H, Constantinou A, Pasero P, Hose D, Moreaux J.

Leukemia. 2017 Oct;31(10):2104-2113. doi: 10.1038/leu.2017.54. Epub 2017 Feb 10.

19.

Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators.

Bros P, Josephs RD, Stoppacher N, Cazals G, Lehmann S, Hirtz C, Wielgosz RI, Delatour V.

Anal Bioanal Chem. 2017 Apr;409(10):2559-2567. doi: 10.1007/s00216-017-0202-4. Epub 2017 Jan 30.

PMID:
28138741
20.

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

Delaby C, Bros P, Vialaret J, Moulinier A, Delatour V, Gabelle A, Lehmann S, Hirtz C.

Bioanalysis. 2017 Feb;9(4):337-347. doi: 10.4155/bio-2016-0240. Epub 2017 Jan 20.

PMID:
28106476

Supplemental Content

Loading ...
Support Center